Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

This update reports pharmacokinetic data and early efficacy signals from a Phase 2 trial of OPT101 in patients with Type 1 diabetes mellitus, with the study cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPT101

Snippet

Sponsor: Op-T LLC | Conditions: Type I Diabetes | Phase 2 | Status: RECRUITING